The wound-healing assay revealed that the LV-ZYX group’s healing area was significantly larger than that of the LV-Control group, indicating that the overexpression of ZYX prevents osteosarcoma cells from migrating (Figure 2E–G). The gene discussed is ZYX; the disease is osteosarcoma.